Catalyst Pharmaceuticals, Inc. (CPRX) NASDAQ
31.27
+0.03999908(+0.13%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
31.27
+0.03999908(+0.13%)
Currency In USD
| Previous Close | 31.23 |
| Open | 31.28 |
| Day High | 31.31 |
| Day Low | 31.27 |
| 52-Week High | 32.56 |
| 52-Week Low | 19.05 |
| Volume | 1.59M |
| Average Volume | 2.07M |
| Market Cap | 3.83B |
| PE | 18.08 |
| EPS | 1.73 |
| Moving Average 50 Days | 27.83 |
| Moving Average 200 Days | 23.72 |
| Change | 0.04 |
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
GlobeNewswire Inc.
Mar 06, 2026 1:03 PM GMT
CORAL GABLES, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients li
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
GlobeNewswire Inc.
Feb 24, 2026 1:03 PM GMT
CORAL GABLES, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
GlobeNewswire Inc.
Feb 11, 2026 1:03 PM GMT
The Company will Host a Conference Call and Webcast on Thursday, February 26, 2026, at 8:30 AM ETCORAL GABLES, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage bioph